Pharmapress 10 mg, 20 mg Tablet

    Pharmapress 10 mg, 20 mg Tablet

    S3
    PDF Leaflet Revision Date: 05 January 2024

    API: Enalapril Maleate | Company: Pharmacare

    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of hypertension and heart failure.

    Dosage (summary)

    Initial: 10-20 mg once daily; Maintenance: 20 mg once daily.

    Special Populations

    • Renal impairment
    • Elderly

    Pregnancy & Breastfeeding

    Contraindicated in pregnancy and breastfeeding.

    Key Drug Interactions

    • Aliskiren
    • Sacubitril/valsartan
    • Potassium-sparing diuretics

    Contraindications

    • Hypersensitivity to enalapril
    • History of angioedema
    • Severe renal impairment

    Common side effects

    • Hypotension
    • Cough
    • Hyperkalaemia

    Counselling Points

    • Monitor blood pressure regularly
    • Avoid potassium supplements
    • Report signs of angioedema immediately

    Serious warnings

    • Risk of renal failure
    • Angioedema
    • Symptomatic hypotension
    Important Disclaimer

    The Pharmapress 10 mg, 20 mg Tablet professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn